<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04601896</url>
  </required_header>
  <id_info>
    <org_study_id>38RC20.225</org_study_id>
    <secondary_id>2020-A01859-30</secondary_id>
    <nct_id>NCT04601896</nct_id>
  </id_info>
  <brief_title>Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018</brief_title>
  <acronym>AQUA</acronym>
  <official_title>Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      If the ExtraCorporeal Membrane Oxygenation (ECMO) improves survival in the management of&#xD;
      refractory cardiac arrest (RCA), this technique is still an invasive technique, not devoid of&#xD;
      complications and requiring intensive care that can have serious consequences for patients.&#xD;
      If the studies so far show an acceptable quality of life post ECMO in refractory cardiac&#xD;
      arrest, the study looks about the quality of life of our patients in Grenoble who survived a&#xD;
      refractory cardiac arrest between 2006 and 2018 at the hospital university Grenoble Alps and&#xD;
      the factors influencing this quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 16, 2020</start_date>
  <completion_date type="Actual">April 27, 2021</completion_date>
  <primary_completion_date type="Actual">January 15, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Global quality of life score</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Items from the SF36 (Short Form 36) survey</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live patients characteristics description</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Demographic and clinical retrospective data collection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital status</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Deed/Lived</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life score related at live patients characteristics description</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Items from the SF36 (Short Form 36) survey matched with live patients characteristics description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life score comparison</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
    <description>Items from the SF36 (Short Form 36) survey compared between the 2 groups ( RCA with /without ECMO) admitted from january 2015 and december 2018</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Refractory Cardiac Arrest</condition>
  <condition>ExtraCorporeal Membrane Oxygenation (ECMO)</condition>
  <arm_group>
    <arm_group_label>Live patients admitted for Refractory Cardiac Arrest with ECMO</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Live patients quality of life admitted for Refractory Cardiac Arrest without ECMO</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SF36 questionnaire via telephone interview</intervention_name>
    <description>SF36 questionnaire via telephone interview</description>
    <arm_group_label>Live patients admitted for Refractory Cardiac Arrest with ECMO</arm_group_label>
    <arm_group_label>Live patients quality of life admitted for Refractory Cardiac Arrest without ECMO</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        monocentric study based on clinical data and quality of life assessement,&#xD;
&#xD;
        Retrospective step :&#xD;
&#xD;
          -  Clinical data collection for live patients admissed for Refractory Cardiac Arrest with&#xD;
             ECMO from january 2006 through december 2018,&#xD;
&#xD;
          -  Clinical data collection for live patients admissed for Refractory Cardiac Arrest&#xD;
             without ECMO from january 2015 through december 2018,&#xD;
&#xD;
        Prospective step:&#xD;
&#xD;
          -  Quality of life assessment via telephone interview based on SF36 questionnaire&#xD;
             performed for live patients admissed for Refractory Cardiac Arrest with ECMO from&#xD;
             january 2006 through december 2018&#xD;
&#xD;
          -  Quality of life assessment via telephone interview based on SF36 questionnaire&#xD;
             performed for live patients admissed for Refractory Cardiac Arrest without ECMO from&#xD;
             january 2015 through december 2018&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult &gt;18 years&#xD;
&#xD;
          -  Admission to intensive care unit after a Refractory Cardiac Arrest&#xD;
&#xD;
          -  Hemodynamic instability after resumption of spontaneous cardiac activity.&#xD;
&#xD;
          -  Non-opposition of the patient or his relatives&#xD;
&#xD;
          -  Admission to intensive care unit From 2006 Through 2018&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ECMO for hypothermia or drug intoxication.&#xD;
&#xD;
          -  Comorbidity contraindicated the ECMO&#xD;
&#xD;
          -  Patients dead before hospital discharge&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Grenoble Alpes</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ExtraCorporeal Membrane Oxygenation (ECMO)</keyword>
  <keyword>Refractory Cardiac Arrest</keyword>
  <keyword>Quality life assessement (SF36 QUESTIONNAIRE)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

